Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 2/3 2Phase 3 1Phase 1 1

Status

Withdrawn 2Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 3NETWORK 2INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 6Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 34Colorectal Neoplasms 26Lung Neoplasms 23Rectal Neoplasms 22Neoplasms 21Esophageal Squamous Cell Carcinoma 20Neoplasm Metastasis 19Esophageal Neoplasms 19Head and Neck Neoplasms 17Stomach Neoplasms 15Pancreatic Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Triple Negative Breast Neoplasms 12Small Cell Lung Carcinoma 12Ovarian Neoplasms 11Nasopharyngeal Carcinoma 10Carcinoma, Squamous Cell 10Recurrence 9Leukemia, Myeloid, Acute 9Colonic Neoplasms 9Uterine Cervical Neoplasms 8Prostatic Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Glioblastoma 7Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Melanoma 6Lymphoma, Non-Hodgkin 6

Interventions

Doxorubicin 62Ifosfamide 39Gemcitabine 29Radiotherapy 27Filgrastim 27Cyclophosphamide 26Docetaxel 19Vincristine 18pembrolizumab 17Etoposide 17pazopanib 16Cisplatin 16Nivolumab 15Trabectedin 14apatinib 13Magnetic Resonance Spectroscopy 13Carboplatin 12Irinotecan 11Bevacizumab 11Temozolomide 10Sirolimus 10camrelizumab 9anlotinib 9Surgical Procedures, Operative 9Sorafenib 9Paclitaxel 9Ipilimumab 9Injections 9Dactinomycin 9Topotecan 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma × Drug Therapy × Clear all
NCT06333314 2025-12-02

Pan-MSI-ACSE

UNICANCER

Phase 2 Recruiting
120 enrolled
EndocrineSarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

NCT04183062 2024-11-08

BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases

Nicklaus Children's Hospital f/k/a Miami Children's Hospital

Phase 2 Withdrawn
Sarcoma

Bone Neoplasms, Sarcoma

NCT03711279 2024-02-29

A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Terminated
99 enrolled 10 charts
Sarcoma

Sarcoma

NCT04589754 2024-01-02

Adriamycin and Ifosfamide Combined With Sintilimab

Sun Yat-sen University

Phase 2 Recruiting
176 enrolled
Sarcoma

Sarcoma

NCT00589121 2019-06-12

Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg

Radiation Therapy Oncology Group

Phase 2 Completed
98 enrolled 17 charts
Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Radiation Fibrosis Syndrome, Lymphedema, Radiation Injuries, Sarcoma

NCT00017160 2013-06-27

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma

Radiation Therapy Oncology Group

Phase 2 Withdrawn
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡